Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism

Journal of Nutrition

Volumn 140, Issue 11, 2010, Pages 1956-1962

  Pinton, Philippe ^a   Braicu, Cornelia ^a,d   Nougayrede, Jean Philippe ^b   Laffitte, Joëlle ^a   Taranu, Ionelia ^a,c   Oswald, Isabelle P ^a  

^a CEMAGREF   (France)

^b IHAP   (France)

^c Institutul National de Cercetare Dezvoltare pentru Biologie si Nutritie Animala Bucharest   (Romania)

^d THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CLAUDIN 4; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P42; PROTEIN P44; VOMITOXIN; ENZYME INHIBITOR; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POISON; TRICHOTHECENE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; EPITHELIUM CELL; INTESTINE EPITHELIUM; INTESTINE FUNCTION; MONOLAYER CULTURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SWINE; TRANSCRIPTION REGULATION; ANIMAL; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; FOOD POISONING; GENETICS; IMPEDANCE; INTESTINE CELL; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ANIMALIA; SUS;

ANIMALS; CELL LINE; CELL MEMBRANE PERMEABILITY; DOWN-REGULATION; ELECTRIC IMPEDANCE; ENTEROCYTES; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOODBORNE DISEASES; INTESTINAL MUCOSA; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; POISONS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SWINE; TIGHT JUNCTIONS; TRICHOTHECENES;

EID: 78149245857     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.123919     Document Type: Article

References (59)

1. Oswald IP, Comera C. Immunotoxicity of mycotoxins. Rev Med Vet. 1998;149:585-90.
2. Council for Agricultural Science and Technology. Mycotoxins: risks in plant, animal and human. Potential economic costs of mycotoxins in United States. Ames (IA): CAST Task Force Report No. 139. 2003;138:136-42.
3. Schothorst RC, van Egmond HP. Report from SCOOP task 3.2.10 "collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states". Subtask: trichothecenes. Toxicol Lett. 2004;153:133-43.
4. Turner PC, Rothwell JA, White KL, Gong Y, Cade JE, Wild CP. Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom. Environ Health Perspect. 2008;116:21-5.
5. Pestka JJ, Smolinski AT. Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev. 2005;8:39-69.
6. Wache YJ, Hbabi-Haddioui L, Guzylack-Piriou L, Belkhelfa H, Roques C, Oswald IP. The mycotoxin deoxynivalenol inhibits the cell surface expression of activation markers in human macrophages. Toxicology. 2009;262:239-44.
7. Pinton P, Accensi F, Beauchamp E, Cossalter AM, Callu P, Grosjean F, Oswald IP. Ingestion of deoxynivalenol (DON) contaminated feed alters the pig vaccinal immune responses. Toxicol Lett. 2008;177:215-22.
8. Moon Y, Pestka JJ. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol Sci. 2002;69:373-82. (Pubitemid 35244211)
9. Zhou HR, Jia Q, Pestka JJ. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck. Toxicol Sci. 2005;85:916-26.
10. Pestka JJ. Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food Addit Contam. 2008;241-13.
11. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol. 1999;71:479-500.
12. Oshima T, Miwa H, Joh T. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am J Physiol Cell Physiol. 2008;295:C800-6.
13. Bouhet S, Oswald IP. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet Immunol Immunopathol. 2005;108:199-209.
14. Soderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol. 2001;280:G7-13.
15. Oswald IP. Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res. 2006;37:359-68.
16. Maresca M, Mahfoud R, Garmy N, Fantini J. The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. J Nutr. 2002;132:2723-31. (Pubitemid 35013261)
17. Bouhet S, Hourcade E, Loiseau N, Fikry A, Martinez S, Roselli M, Galtier P, Mengheri E, Oswald IP. The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicol Sci. 2004;77:165-71.
18. Kolf-Clauw M, Castellote J, Joly B, Bourges-Abella N, Raymond-Letron I, Pinton P, Oswald IP. Development of a pig jejunal explant culture for studying the gastrointestinal toxicity of the mycotoxin deoxynivalenol: histopathological analysis. Toxicol In Vitro. 2009;23:1580-4.
19. Kasuga F, Hara-Kudo Y, Saito N, Kumagai S, Sugita-Konishi Y. In vitro effect of deoxynivalenol on the differentiation of human colonic cell lines Caco-2 and T84. Mycopathologia. 1998;142:161-7.
20. Sergent T, Parys M, Garsou S, Pussemier L, Schneider YJ, Larondelle Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol Lett. 2006;164:167-76.
21. Pinton P, Nougayrede JP, Del Rio JC, Moreno C, Marin DE, Ferrier L, Bracarense AP, Kolf-Clauw M, Oswald IP. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol. 2009;237:41-8.
22. Gonzalez-Vallina R, Wang H, Zhan R, Berschneider HM, Lee RM, Davidson NO, Black DD. Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am J Physiol. 1996;271:G249-59.
23. Meissonnier GM, Pinton P, Laffitte J, Cossalter AM, Gong YY, Wild CP, Bertin G, Galtier P, Oswald IP. Immunotoxicity of aflatoxin B1: impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression. Toxicol Appl Pharmacol. 2008;231:142-9.
24. Peirson SN, Butler JN, Foster RG. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 2003;31:e73.
25. Le Gall M, Gallois M, Seve B, Louveau I, Holst JJ, Oswald IP, Lalles JP, Guilloteau P. Comparative effect of orally administered sodium butyrate before or after weaning on growth and several indices of gastrointestinal biology of piglets. Br J Nutr. 2009;102:1285-96.
26. Schaffner W, Weissmann C. A rapid, sensitive and specific method for the determination of protein in dilute solution. Anal Biochem. 1973;56:502-14.
27. Lipschutz JH, Li S, Arisco A, Balkovetz DF. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem. 2005;280:3780-8. (Pubitemid 40223847)
28. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-20.
29. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124:3-20.
30. Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet. 1989;1:35-7.
31. SCOOP. Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. Directorate-general health and consumer protection. 2003 [cited 2010 July 19]. Available from: http://ec.europa.eu/food/fs/scoop/task3210.pdf.
32. Trucksess MW, Thomas F, Young K, Stack ME, Fulgueras WJ, Page SW. Survey of deoxynivalenol in U.S. 1993 wheat and barley crops by enzyme-linked immunosorbent assay. J AOAC Int. 1995;78:631-6.
33. Abouzied MM, Azcona JI, Braselton WE, Pestka JJ. Immunochemical assessment of mycotoxins in 1989 grain foods: evidence for deoxynivalenol (vomitoxin) contamination. Appl Environ Microbiol. 1991;57:672-7.
34. Zhou HR, Islam Z, Pestka JJ. Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin. Toxicol Sci. 2003;72:130-42.
35. Shifrin VI, Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 1999;274:13985-92.
36. Bimczok D, Doll S, Rau H, Goyarts T, Wundrack N, Naumann M, Danicke S, Rothkotter HJ. The Fusarium toxin deoxynivalenol disrupts phenotype and function of monocyte-derived dendritic cells in vivo and in vitro. Immunobiology. 2007;212:655-66.
37. Moon Y, Yang H, Lee SH. Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells. Biochem Biophys Res Commun. 2007;362:256-62. (Pubitemid 47332399)
38. Yang H, Chung DH, Kim YB, Choi YH, Moon Y. Ribotoxic mycotoxin deoxynivalenol induces G(2)/M cell cycle arrest via p21(Cip/WAF1) mRNA stabilization in human epithelial cells. Toxicology. 2008;243:145-54.
39. Madara JL. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol. 1998;60:143-59.
40. Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut. 2004;53:1295-302.
41. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol. 2008;130:55-70.
42. Lamb-Rosteski JM, Kalischuk LD, Inglis GD, Buret AG. Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation. Infect Immun. 2008;76:3390-8.
43. McLaughlin J, Padfield PJ, Burt JP, O'Neill CA. Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms. Am J Physiol Cell Physiol. 2004;287:C1412-7.
44. Michikawa H, Fujita-Yoshigaki J, Sugiya H. Enhancement of barrier function by overexpression of claudin-4 in tight junctions of submandibular gland cells. Cell Tissue Res. 2008;334:255-64.
45. Lanaspa MA, Andres-Hernando A, Rivard CJ, Dai Y, Berl T. Hypertonic stress increases claudin-4 expression and tight junction integrity in association with MUPP1 in IMCD3 cells. Proc Natl Acad Sci USA. 2008;105:15797-802.
46. Basuroy S, Sheth P, Kuppuswamy D, Balasubramanian S, Ray RM, Rao RK. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem. 2003;278:11916-24.
47. Chen Y, Lu Q, Schneeberger EE, Goodenough DA. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell. 2000;11:849-62.
48. Lowell CA. Src-family kinases: rheostats of immune cell signaling. Mol Immunol. 2004;41:631-43.
49. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol. 1995;269:G467-75.
50. Basuroy S, Seth A, Elias B, Naren AP, Rao R. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J. 2006;393:69-77. (Pubitemid 43049303)
51. Ikari A, Atomi K, Takiguchi A, Yamazaki Y, Miwa M, Sugatani J. Epidermal growth factor increases claudin-4 expression mediated by Sp1 elevation in MDCK cells. Biochem Biophys Res Commun. 2009;384:306-10.
52. De Walle JV, Sergent T, Piront N, Toussaint O, Schneider YJ, Larondelle Y. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis. Toxicol Appl Pharmacol. 2010;245:291-8.
53. Findley MK, Koval M. Regulation and roles for claudin-family tight junction proteins. IUBMB Life. 2009;61:431-7.
54. Tanaka M, Kamata R, Sakai R. EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability. J Biol Chem. 2005;280:42375-82.
55. Aono S, Hirai Y. Phosphorylation of claudin-4 is required for tight junction formation in a human keratinocyte cell line. Exp Cell Res. 2008;314:3326-39.
56. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci. 2006;119:2095-106.
57. Patrick DM, Leone AK, Shellenberger JJ, Dudowicz KA, King JM. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol. 2006;6:2.
58. Bouhet S, Le Dorze E, Peres S, Fairbrother JM, Oswald IP. Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies. Food Chem Toxicol. 2006;44:1768-73. (Pubitemid 44216085)
59. Sergent T, Ribonnet L, Kolosova A, Garsou S, Schaut A, De Saeger S, Van Peteghem C, Larondelle Y, Pussemier L, et al. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chem Toxicol. 2008;46:813-41.